Meet the ACE TA Center: Microlearning Module
Resource updated 10/30/2023
Resource updated 10/30/2023
Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Medicare-Medicaid dual eligibility can be a complex topic with many nuances.
This tool is intended to help people with HIV understand the basics of eligibility and coverage, the unique benefits of being dually eligible for both programs, as well as how the Ryan White HIV/AIDS Program (RWHAP) can support dually eligible clients.
This tool covers:
Resource updated 01/12/2024
Resource updated 06/06/2024
Review of how trauma-informed care services were implemented in a medical clinic and community organization, health department implementation actions, and client perspectives on these services.
Resource updated 11/07/2023
Insights on ways that HIV care programs have improved health outcomes along the HIV care continuum.
Resource updated 03/13/2024
Highlights from linkage to care projects in correctional settings.
Resource updated 08/26/2022
Resource updated 08/29/2022
Review of how RWHAP Part B programs develop, maintain, and evaluate service standards for all funded services, per Policy Clarification Notice (PCN) 16-02.
Resource updated 09/14/2023
Activities agencies can undertake to enhance delivery of HIV care to youth living with HIV.
Resource updated 09/19/2023
HIV clinical training resources for HRSA's AIDS Education and Training Centers Program.
Resource updated 07/18/2024
Online clinician training platform with evidence-based core competency training on HIV prevention, screening, diagnosis, care, and key populations.
Resource updated 07/18/2024
Resource updated 07/18/2024
Resource updated 07/19/2024
NASTAD’s National AIDS Drug Assistance Program (ADAP) Formulary Database provides an online, searchable, publicly available resource detailing state-by-state ADAP coverage of medications, including HIV antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, mental health and substance use treatment medications, and various vaccines and laboratory tests.
Resource updated 03/07/2024
Resource from the RWHAP Best Practices Compilation updated on 07/11/2024
Resource from the RWHAP Best Practices Compilation updated on 05/20/2024
Resource from the RWHAP Best Practices Compilation updated on 05/24/2024